Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT04877002
Eligibility Criteria:
Inclusion Criteria:
Up to 500 subjects will be screened, consented, and enrolled to obtain a minimum of 50 eligible candidates. In order to be eligible to participate in this study, an individual must meet all of the following criteria:
1. Presenting to the Emergency Department at HRH.
2. Receiving a COVID-19 RT-PCR test as per standard pathway of care.
3. Provide written informed consent.
4. Patients must be presenting or have experienced at least one (1) or more signs or symptoms of COVID-19 within ≤ 7 days:
1. Fever as self-described or measured ≥ 38 °C (100.4°F)
2. Chills
3. Cough
4. Shortness of breath
5. Congestion or runny nose
6. Difficulty Breathing
7. Muscle or Body Aches
8. Vomiting
9. Diarrhea
10. New loss of sense of taste or smell
11. Headache
12. General malaise
13. Sore Throat
Exclusion Criteria:
1. Asymptomatic patients.
2. Patients unable to provide a saliva sample.
3. Patients unable to give consent.
4. Patients who will not be receiving a nasopharyngeal RT-PCR test.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04877002
Study Brief:
Protocol Section:
NCT04877002